Clinical Trials Browser

Phase EARLY_PHASE1 × Multiple Myeloma × 13-valent pneumococcal vaccine × Clear all

NCT02851056 2022-11-14

Survivin Vaccine : Multiple Myeloma Autologous Hematopoietic Cell Transplant (HCT)

Phase EARLY_PHASE1 Completed

Multiple Myeloma, Neoplasms, Plasma Cell